SE413245B - Forfarande for framstellning av optiskt aktiv (+)-lakton- eller -tiolakton-forening - Google Patents

Forfarande for framstellning av optiskt aktiv (+)-lakton- eller -tiolakton-forening

Info

Publication number
SE413245B
SE413245B SE7308696A SE7308696A SE413245B SE 413245 B SE413245 B SE 413245B SE 7308696 A SE7308696 A SE 7308696A SE 7308696 A SE7308696 A SE 7308696A SE 413245 B SE413245 B SE 413245B
Authority
SE
Sweden
Prior art keywords
tolakton
lakton
society
procedure
optical active
Prior art date
Application number
SE7308696A
Other languages
English (en)
Swedish (sv)
Inventor
Y Aoki
H Suzuki
H Akiyama
S Okano
Original Assignee
Sumitomo Chemical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP6303272A external-priority patent/JPS5516435B2/ja
Priority claimed from JP3391273A external-priority patent/JPS5335076B2/ja
Application filed by Sumitomo Chemical Co filed Critical Sumitomo Chemical Co
Publication of SE413245B publication Critical patent/SE413245B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30Oxygen or sulfur atoms
    • C07D233/32One oxygen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SE7308696A 1972-06-22 1973-06-20 Forfarande for framstellning av optiskt aktiv (+)-lakton- eller -tiolakton-forening SE413245B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP6303272A JPS5516435B2 (US20110009641A1-20110113-C00273.png) 1972-06-22 1972-06-22
JP3391273A JPS5335076B2 (US20110009641A1-20110113-C00273.png) 1973-03-23 1973-03-23

Publications (1)

Publication Number Publication Date
SE413245B true SE413245B (sv) 1980-05-12

Family

ID=26372681

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7308696A SE413245B (sv) 1972-06-22 1973-06-20 Forfarande for framstellning av optiskt aktiv (+)-lakton- eller -tiolakton-forening

Country Status (13)

Country Link
US (1) US3876656A (US20110009641A1-20110113-C00273.png)
AT (1) AT325038B (US20110009641A1-20110113-C00273.png)
CA (1) CA1020561A (US20110009641A1-20110113-C00273.png)
CH (2) CH593286A5 (US20110009641A1-20110113-C00273.png)
DD (2) DD111577A5 (US20110009641A1-20110113-C00273.png)
DE (1) DE2331244C3 (US20110009641A1-20110113-C00273.png)
DK (1) DK137333B (US20110009641A1-20110113-C00273.png)
FR (1) FR2197887B1 (US20110009641A1-20110113-C00273.png)
GB (2) GB1420510A (US20110009641A1-20110113-C00273.png)
HU (1) HU167852B (US20110009641A1-20110113-C00273.png)
NL (1) NL7308766A (US20110009641A1-20110113-C00273.png)
PL (1) PL90072B1 (US20110009641A1-20110113-C00273.png)
SE (1) SE413245B (US20110009641A1-20110113-C00273.png)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5315076B2 (US20110009641A1-20110113-C00273.png) * 1973-09-27 1978-05-22
JPS603387B2 (ja) * 1980-07-10 1985-01-28 住友化学工業株式会社 新規光学活性イミダゾリジン−2−オン誘導体およびその製法
EP0173185B1 (de) * 1984-08-25 1990-01-31 MERCK PATENT GmbH Verfahren zur Herstellung von (3a5,6aR)-und/oder(3aR,6a5)-1,3-Dibenzyl-hexahydro-1H-furo(3,4-d)imidazol-2,4-dion
CH670644A5 (US20110009641A1-20110113-C00273.png) * 1986-12-18 1989-06-30 Lonza Ag
DE4107121C1 (US20110009641A1-20110113-C00273.png) * 1991-03-06 1992-06-11 Merck Patent Gmbh, 6100 Darmstadt, De
US6495125B2 (en) * 1999-01-08 2002-12-17 The Procter & Gamble Company Topical compositions comprising protected functional thiols
CN100381443C (zh) * 2003-10-23 2008-04-16 浙江医药股份有限公司新昌制药厂 一种酰亚胺衍生物的制备方法
CN103242342B (zh) * 2013-04-27 2015-09-16 浙江新和成股份有限公司 1,3-烷基四氢噻吩并[3,4-d]咪唑-2(3H)-4-二酮化合物的制备方法
US10689349B2 (en) 2016-08-04 2020-06-23 Tokuyama Corporation Method for producing intermediate of biotin and method for producing biotin
CN107686488B (zh) * 2016-08-05 2020-04-28 浙江医药股份有限公司新昌制药厂 一种生物素中间体的合成方法
JP6856471B2 (ja) * 2017-01-04 2021-04-07 株式会社トクヤマ ラクトン化合物の製造方法、および該ラクトン化合物を使用したビオチンの製造方法
CN114450261B (zh) * 2019-10-01 2024-07-09 株式会社德山 三酮化合物的制造方法
CN115557958B (zh) * 2021-07-02 2024-05-28 浙江医药股份有限公司新昌制药厂 一种制备生物素中间体光学活性内酯的方法
CN114790211B (zh) * 2022-04-22 2023-11-17 浙江花园营养科技有限公司 一种生物素及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3687967A (en) * 1969-02-24 1972-08-29 Hoffmann La Roche {60 -dehydrobiotin synthesis
US3700659A (en) * 1970-11-17 1972-10-24 Hoffmann La Roche (+)-cis - 1,3-dibenzyl-hexahydro-1h-furo-(3,4-d)imidazole - 2,4 - dione,processes and intermediates

Also Published As

Publication number Publication date
DD107932A5 (US20110009641A1-20110113-C00273.png) 1974-08-20
CH602740A5 (US20110009641A1-20110113-C00273.png) 1978-07-31
FR2197887B1 (US20110009641A1-20110113-C00273.png) 1977-07-29
DE2331244B2 (de) 1977-07-14
FR2197887A1 (US20110009641A1-20110113-C00273.png) 1974-03-29
DD111577A5 (US20110009641A1-20110113-C00273.png) 1975-02-20
AT325038B (de) 1975-09-25
DE2331244C3 (de) 1978-03-02
GB1420509A (en) 1976-01-07
DK137333B (da) 1978-02-20
GB1420510A (en) 1976-01-07
HU167852B (US20110009641A1-20110113-C00273.png) 1975-12-25
CH593286A5 (US20110009641A1-20110113-C00273.png) 1977-11-30
US3876656A (en) 1975-04-08
CA1020561A (en) 1977-11-08
NL7308766A (US20110009641A1-20110113-C00273.png) 1973-12-27
DK137333C (US20110009641A1-20110113-C00273.png) 1978-07-24
PL90072B1 (en) 1976-12-31
DE2331244A1 (de) 1974-01-10

Similar Documents

Publication Publication Date Title
SE404019B (sv) Forfarande for framstellnig av n-fosfonometylglycin
BR7301058D0 (pt) Penso
SE398319B (sv) Anordning for deckframstellning
IT995560B (it) Portapezzo per lenti ottiche
SE408750B (sv) Katamenial tampong
SE404338B (sv) Fotoelektriskt ljusmanovrerande anordning for fordon
FI56312B (fi) Anordning foer fastsaettning av vaeggbeklaednad
SE417968B (sv) Forfarande for framstellning av penamderivat
SE413245B (sv) Forfarande for framstellning av optiskt aktiv (+)-lakton- eller -tiolakton-forening
NO140478C (no) Fremgangsmaate for fremstilling av fibriller
SE395796B (sv) Optisk kavitet for laser
FI55336C (fi) Foerfarande foer framstaellning av som antianginala laekemedel anvaendbara 2-alkyl-3-(4-ny-di-n-butylamino-propoksbensoyl)-bensofuranderivat
SE392671B (sv) Hallare for blixtlaslopare
SE381980B (sv) Paleggare for harfergning
NO149734C (no) Fremgangsmaate for fremstilling av urea
FI55626C (fi) Anordning foer framstaellning av en behaollare
SE423092B (sv) Forfarande for framstellning av vissa 13-tiaprostaglandiner
AT333051B (de) Pankratisches objektiv
SE390790B (sv) Lopare for blixtlas
SE386580B (sv) Hallare for blixtlaslopare
SE385123B (sv) Sett att framstella racemisk eller optiskt aktiv 13beta-etyl-17alfa-etynyl-gon-4-en-3-on-17beta-ol
NO147644C (no) Fremgangsmaate for fremstilling av 6-amino-penicillansyre
FI56670B (fi) Foerfarande foer framstaellning av 5-cyklohexyl-6-halogenindan-1-karboxylsyraderivat
TR17286A (tr) Ueretanlarin imaline mahsus usul
NO139948C (no) Anordning for sammenskjoeting av presenninger